Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study.
Sruthi AdimadhyamTodd A LeeGregory Sampang CalipDaphne E Smith MarshBrian T LaydenGlen T SchumockPublished in: Diabetes, obesity & metabolism (2018)
All SGLT2i had an elevated, though not statistically significant, risk for amputations.
Keyphrases